Exosomes Market Research Report by Application (Cardiovascular Diseases, Genetic Disorders, Infectious Diseases, Neurodegenerative Diseases, and Oncology), by End-User (Cancer Institutes, Diagnostic Centers, Hospitals, and Research Laboratories) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Exosomes Market is expected to grow from USD 572.89 Million in 2020 to USD 1,342.55 Million by the end of 2025. 2. The Global Exosomes Market is expected to grow from EUR 502.32 Million in 2020 to EUR 1,177.17 Million by the end of 2025. 3. The Global Exosomes Market is expected to grow from GBP 446.56 Million in 2020 to GBP 1,046.50 Million by the end of 2025. 4. The Global Exosomes Market is expected to grow from JPY 61,141.88 Million in 2020 to JPY 143,284.14 Million by the end of 2025. 5. The Global Exosomes Market is expected to grow from AUD 831.91 Million in 2020 to AUD 1,949.56 Million by the end of 2025.
Market Segmentation & Coverage: This research report categorizes the Exosomes to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Application, the Exosomes Market studied across Cardiovascular Diseases, Genetic Disorders, Infectious Diseases, Neurodegenerative Diseases, and Oncology.
Based on End-User, the Exosomes Market studied across Cancer Institutes, Diagnostic Centers, Hospitals, and Research Laboratories.
Based on Geography, the Exosomes Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles: The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Exosomes Market including Aegle Therapeutics Corporation, Anjarium Biosciences AG, ArunA Bio, Inc., Bio-Techne Corporation, Codiak BioSciences Inc., Evox Therapeutics Limited, ExCoBio Inc., Kimera Society Inc., and Takara Bio Company.
Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch™ FPNV Positioning Matrix: The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Exosomes Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch™ Competitive Strategic Window: The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as: 1. What is the market size and forecast of the Global Exosomes Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Exosomes Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Exosomes Market? 4. What is the competitive strategic window for opportunities in the Global Exosomes Market? 5. What are the technology trends and regulatory frameworks in the Global Exosomes Market? 6. What are the modes and strategic moves considered suitable for entering the Global Exosomes Market?
Our reports have been used by over 10K customers, including:
The North America organoids market is expected to reach US$ 1,406.47 million by 2027 from US$ 291.39 million in 2019. The market is anticipated to grow at a CAGR of 21.7% from 2020 to 2027. Growth of the North America organoids market is attributed to emergence of three-dimensional (3D) organoids and rise in investments in research. However,...
The Asia Pacific organoids market is expected to reach US$ 513.74 million in 2027 from US$ 97.02 million in 2019. The market is estimated to grow at a CAGR of 23.1% from 2020 to 2027. Rising adoption of biobanking and tumor modelling and alternatives for animal testing models acting as kingpins are expected to augment the growth of the...
The Europe organoids market is projected to reach US$ 1,260.08 million by 2027 from US$ 247.85 million in 2019; it is estimated to grow at a CAGR of 22.5% from 2020 to 2027. Increasing demand for tumor modelling and biobanking and rising adoption of personalized drugs are expected to drive the market. Personalized medicine is a growing...
The Middle East & Africa organoids market is expected to reach US$ 141.26 million in 2027 from US$ 37.34 million in 2019; the market is estimated to grow at a CAGR of 20.9% from 2020 to 2027. The growth of the market can be attributed to growing research on organoids in the Middle East & Africa region and rising focus on developing alternatives...
The South and Central America nurse call systems market is expected to reach US$ 200.11 million by 2027 from US$ 87.23 million in 2019. The market is estimated to grow at a CAGR of 10.8% from 2020-2027. The growth of the South and Central America nurse call systems market is driven by the growing incidence of Alzheimer’s disease and dementia...
The global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019. The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. Increasing demand for tumor modelling and biobanking, rising adoption of personalized drugs, and growing focus on developing alternatives for animal testing...
The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected...
Anatomic Pathology Market Report Overview Anatomic Pathology market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Anatomic Pathology market types and applications. It is a focused study on Anatomic Pathology market space including global...
The current practice of medical education and methods of performing surgery and therapy suffer from limitations such as scarcity of subjects to practice on, suboptimal surgical precision, and therapy-related issues including medication misuse and ineffectiveness of the drugs to treat the conditions. Moreover, the outbreak of COVID-19 pandemic...
Healthy future: Despite the mounting likelihood of new regulation, industry revenue will likely grow Abstract Cryogenic Biobanking Services Since the landmark scientific achievement of human genome sequencing in 2003, the Cryogenic Biobanking Services industry is increasingly viewed as the link between...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.